Fentanyl remains one of the most serious substances in Kentucky’s illicit drug supply, but fentanyl itself is no longer the only concern.
The illegal drug market has become increasingly unpredictable as fentanyl appears alongside veterinary sedatives, synthetic benzodiazepines, other powerful synthetic opioids, stimulants, heroin and counterfeit prescription pills.
Someone may believe they are using heroin, cocaine, methamphetamine or a prescription medication without knowing that fentanyl is present. Someone intentionally using fentanyl may also have no reliable way of knowing what other substances have been added.
Kentucky public health officials now warn that fentanyl and nitazenes may appear in heroin, methamphetamine, cocaine and pills, while xylazine, medetomidine and benzodiazepine-like substances may also be present in unregulated drugs.
At Lexington Addiction Center, treatment focuses on helping people continue recovery after stabilization through structured addiction and co-occurring mental health treatment, including partial hospitalization, intensive outpatient treatment and outpatient care.
Kentucky has made meaningful progress in reducing overdose deaths, but fentanyl remains a major part of the state’s overdose environment.
The changing concern is increasingly a polysubstance drug supply in which fentanyl may appear alongside other opioids, stimulants, veterinary sedatives and synthetic benzodiazepine-like substances.
That makes today’s illicit drug market harder to predict and can affect overdose response, withdrawal symptoms and treatment needs.
The contents of illegal drugs can change quickly. A substance detected in one Kentucky community may not appear in another, and even products obtained from the same source may vary between batches.
The following substances are known or emerging parts of Kentucky’s changing illicit drug environment.
Medetomidine is a potent veterinary sedative that has emerged in the illicit fentanyl supply.
The University of Kentucky College of Public Health has reported that medetomidine has been found in the illicit fentanyl supply in several Kentucky counties.
This matters because someone may knowingly use fentanyl while being repeatedly exposed to medetomidine without realizing it.
Medetomidine is not an opioid. Naloxone can reverse opioid effects caused by fentanyl but does not directly reverse medetomidine.
Naloxone should still be administered whenever opioid overdose is suspected because fentanyl or another opioid may be present.
Repeated medetomidine exposure has also been associated with potentially severe withdrawal symptoms that may require medical treatment.
Xylazine is another veterinary sedative associated with illicit fentanyl.
Often called tranq, xylazine is not an opioid and is not approved for human use.
Kentucky overdose toxicology data and wastewater surveillance have documented xylazine in the state.
Fentanyl is an opioid, while xylazine is a sedative. Together they can contribute to profound sedation and make an overdose more difficult to manage.
Naloxone can reverse fentanyl’s opioid effects but does not directly reverse xylazine.
Xylazine exposure has also been associated with serious skin and soft-tissue injuries that may require medical care.
Both substances are veterinary sedatives that can appear with illicit opioids, but they are not the same drug.
A newer emerging sedative detected in Kentucky’s fentanyl supply. Severe withdrawal after repeated exposure has become an important concern.
A veterinary sedative often called tranq that has been documented in Kentucky and linked to profound sedation and serious wounds.
Bromazolam is a synthetic benzodiazepine-like substance sometimes described as designer Xanax.
It has been identified in Kentucky overdose toxicology data and has also appeared in counterfeit pills.
Bromazolam produces depressant effects similar to benzodiazepines. Combining a powerful opioid such as fentanyl with another central nervous system depressant can contribute to profound sedation and impaired consciousness.
Naloxone can reverse fentanyl’s opioid effects but does not directly reverse bromazolam.
Nitazenes are a family of synthetic opioids that have become another concern within the changing illegal drug market.
Kentucky public health guidance now includes nitazenes among substances that may appear in heroin, methamphetamine, cocaine and counterfeit pills.
Both fentanyl and nitazenes are synthetic opioids, but they are chemically different.
Some nitazene compounds can be extraordinarily potent, which makes unknown combinations particularly dangerous.
Because nitazenes are opioids, naloxone may help reverse their opioid effects. Multiple doses may sometimes be necessary during overdoses involving highly potent synthetic opioids.
Kentucky public health guidance warns that fentanyl may appear in unregulated methamphetamine. Someone intending to use a stimulant may therefore be exposed to an opioid unexpectedly.
Fentanyl may also appear in cocaine, creating overdose risk for people who may have little or no opioid tolerance.
A person purchasing heroin may instead receive fentanyl, fentanyl analogs or another synthetic opioid.
Illegal pills can be manufactured to resemble oxycodone, hydrocodone or Xanax while containing fentanyl, nitazenes, bromazolam or other substances.
The larger issue is not simply fentanyl. It is the unpredictability of the entire illicit drug supply.
A sample may contain an opioid, stimulant and sedative at the same time.
Someone may believe they have developed dependence on one substance while their nervous system has repeatedly been exposed to several.
This changing environment has implications for overdose prevention, medical stabilization, withdrawal management and long-term addiction treatment.
Opioid withdrawal is already difficult. An unpredictable drug supply can make it more complicated.
A person who believes they have been using fentanyl may also have experienced repeated exposure to medetomidine, xylazine, bromazolam or other drugs.
Different substances can produce different withdrawal syndromes. Medetomidine is particularly important because severe withdrawal has been reported following repeated exposure.
A medical assessment can help determine whether detoxification or another level of medical care is necessary.
Usually not by looking at it.
Illegal powders and counterfeit pills can contain substances that cannot reliably be identified by sight, smell or taste.
Kentucky provides drug-checking information for substances including fentanyl, nitazenes, xylazine, medetomidine and benzodiazepines.
Testing may reduce uncertainty, but it cannot make an illicit drug safe.
Possible signs of opioid overdose can include:
A suspected overdose is a medical emergency.
Call 911 and administer naloxone when an opioid may be involved.
Yes, but naloxone specifically reverses opioid effects.
It can therefore reverse opioid toxicity caused by fentanyl and other opioids, but it does not directly reverse non-opioid sedatives such as xylazine or medetomidine.
Kentucky has reported meaningful declines in overdose deaths in recent years.
That progress matters, but the toxicology data continue to show a complicated illicit drug environment involving fentanyl, methamphetamine, xylazine, bromazolam, heroin and other substances.
The drug supply continues to evolve even as overdose prevention efforts save lives.
Detoxification addresses withdrawal and medical stabilization. It does not address every factor that contributes to opioid addiction.
PHP provides substantial daytime therapeutic structure for people who have completed stabilization but still need intensive support.
IOP provides structured therapy, relapse prevention and recovery support while allowing greater flexibility for daily responsibilities.
Outpatient care can help clients continue therapy, relapse prevention and recovery planning as they return to everyday routines.
Integrated treatment can address depression, anxiety, trauma, PTSD, bipolar disorder and other mental health concerns that may affect substance use and recovery.
At Lexington Addiction Center, treatment focuses on the individual rather than assuming that one drug explains every part of the person’s addiction.
Someone seeking help for fentanyl addiction may also have been exposed to methamphetamine, benzodiazepine-like drugs, xylazine, medetomidine or other synthetic opioids.
They may also be experiencing depression, anxiety, trauma, PTSD, bipolar disorder or another mental health condition that influences substance use and recovery.
Depending on clinical needs, treatment may include partial hospitalization, intensive outpatient treatment, outpatient treatment, individual therapy, group therapy, behavioral therapies, relapse prevention, medication support when clinically appropriate and co-occurring mental health treatment.
Kentucky public health authorities warn that fentanyl and other potent opioids such as nitazenes may appear in heroin, methamphetamine, cocaine and counterfeit pills. Xylazine, medetomidine and benzodiazepine-like substances are also concerns.
Yes. The University of Kentucky College of Public Health reports that medetomidine has been identified in the illicit fentanyl supply in several Kentucky counties.
Rhino tranq is an informal street term sometimes used for medetomidine, a veterinary sedative increasingly detected in illicit fentanyl.
No. Both are veterinary sedatives that have appeared alongside illicit opioids, but they are different substances. Neither is an opioid.
Yes. Kentucky overdose toxicology data and wastewater surveillance have documented xylazine in the state.
Bromazolam is a synthetic benzodiazepine-like substance sometimes described as designer Xanax. It has appeared in Kentucky overdose toxicology data and counterfeit pills.
Kentucky public health guidance includes nitazenes in current drug-checking and harm-reduction information and warns that they may appear in unregulated drugs.
Yes. Kentucky public health guidance warns that fentanyl may occur in unregulated methamphetamine.
Yes. Fentanyl can appear in cocaine, creating a risk of unexpected opioid exposure for people intending to use stimulants.
Yes. Counterfeit pills can contain fentanyl, nitazenes, synthetic benzodiazepine-like drugs or other unexpected substances.
Naloxone does not directly reverse xylazine, but it should still be administered whenever fentanyl or another opioid may be involved.
Naloxone does not directly reverse medetomidine. It should still be administered when opioid overdose is suspected because fentanyl may also be present.
Yes. Someone using illicit fentanyl may have unknowingly experienced repeated exposure to additional substances. Medetomidine is particularly important because repeated exposure has been associated with severe withdrawal.
People who need medical stabilization or detoxification should complete that level of care first. Lexington Addiction Center provides structured addiction and co-occurring mental health treatment through PHP, IOP and outpatient programs for people who are medically appropriate for outpatient care.
This article is educational and does not replace an individualized medical assessment. The illicit drug supply can change rapidly, and people may not know which substances they have been exposed to without laboratory testing.
Board-Certified Psychiatrist & Addictionologist
Licensed Clinical Social Worker
A person does not need to know exactly what was contained in every drug they used before seeking treatment.
If fentanyl or other opioid use has become difficult to stop, Lexington Addiction Center can help you understand the next appropriate level of care after stabilization.
If you or someone around you is experiencing a suspected overdose, severe withdrawal or another medical emergency, call 911 immediately.
At Lexington Addiction Center, we believe that recovery is a journey, not a destination. That’s why we offer a comprehensive continuum of care, delivered by a team of experienced and compassionate professionals. Our team is made up of licensed therapists, counselors, nurses, and other professionals who are passionate about helping people achieve lasting sobriety. Whether you are just starting your recovery journey or you are a seasoned veteran, we are here to support you every step of the way. We believe in you, and we are committed to helping you achieve your recovery goals.
Explore Lexington Addiction Center’s drug & alcohol detox rehab treatment center in Lexington, KY and step into private therapy offices, spacious group rooms, and tranquil lounges where thoughtful design supports every stage of substance-use recovery.
Addiction and co-occurring disorders don’t have to control your life. Lexington Addiction Center is waiting with open arms to give you the tools necessary for lasting change. Reach out to us today to learn more.
